Federation Des Caisses Desjardins Du Quebec Emergent Bio Solutions Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.4 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.5 - $3.41 $6 - $13	4 New	4 $10,000
Q4 2022 Aug 14, 2024	SELL	$11.0 - $21.45 $282,700 - $551,265	-25,700 Reduced 99.98%	4 $47,000
Q3 2022 Aug 14, 2024	BUY	$20.09 - $35.8 $102,459 - $182,580	5,100 Added 24.75%	25,704 $540 Million
Q2 2022 Aug 14, 2024	SELL	$27.42 - $43.63 $1,645 - $2,617	-60 Reduced 0.29%	20,604 $640 Million
Q1 2022 Aug 14, 2024	BUY	$36.48 - $52.22 $753,822 - $1.08 Million	20,664 New	20,664 $848 Million
Q4 2021 Aug 30, 2024	SELL	$33.11 - $55.01 $301,301 - $500,591	-9,100 Reduced 34.91%	16,964 $737 Million
Q3 2021 Aug 30, 2024	BUY	$50.07 - $66.05 $1.3 Million - $1.72 Million	26,000 Added 40625.0%	26,064 $1.3 Billion
Q2 2021 Aug 30, 2024	BUY	$56.61 - $80.46 $3,623 - $5,149	64 New	64 $4.03 Million
Q3 2020 Aug 30, 2024	SELL	$81.91 - $134.94 $5,324 - $8,771	-65 Reduced 50.39%	64 $6.61 Million
Q2 2020 Aug 30, 2024	BUY	$54.33 - $89.52 $7,008 - $11,548	129 New	129 $10.2 Million
Q3 2018 Aug 30, 2024	SELL	$52.05 - $66.51 $620,123 - $792,400	-11,914 Closed	0 $0
Q2 2018 Aug 30, 2024	SELL	$48.33 - $55.64 $169,299 - $194,906	-3,503 Reduced 22.72%	11,914 $602 Million
Q3 2017 Aug 30, 2024	BUY	$34.14 - $40.45 $424,667 - $503,157	12,439 Added 417.7%	15,417 $625 Million
Q2 2017 Aug 30, 2024	SELL	N/A	-6,754 Reduced 69.4%	2,978 $101 Million
Q1 2017 Aug 30, 2024	BUY	N/A	9,732	9,732 $282 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account